期刊文献+

增强磁共振成像与胆胰管成像对胰腺导管内乳头状黏液性肿瘤良恶性鉴别的比较 被引量:8

Comparison of Enhanced Magnetic Resonance Imaging and Magnetic Resonance Cholangiopancreatography in the Differential Diagnosis of Benign and Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas
下载PDF
导出
摘要 目的比较肝脏容积加速采集增强磁共振成像(LAVA)扫描和磁共振胆胰管成像(MRCP)对胰腺导管内乳头状黏液性肿瘤(IPMN)的良恶性鉴别诊断价值。方法回顾性分析了经病理证实的35例胰腺IPMN患者的磁共振(MR)资料,所用序列包括T1WI、T2WI、LAVA增强MRI和MRCP。将所有患者的MR资料分成增强MRI组(诊断方法包括T1 WI、T2 WI和增强MRI)和MRCP组(诊断方法包括T1 WI、T2 WI和MRCP)进行比较,采用受试者工作特征曲线(ROC)分析两组诊断方法对IPMN良恶性鉴别诊断的价值。结果共确诊胰腺导管内乳头状黏液瘤23例和黏液癌12例,增强MRI组鉴别诊断的准确度为82.9%(29/35),高于MRCP组的71.4%(25/35),但两者差异无统计学意义(P=0.068)。增强MRI组诊断方法的敏感性、特异性、阳性预测值和ROC曲线下面积(AUC)分别为83.3%、82.6%、71.4%和0.850,MRCP组分别为75.0%、69.6%、52.3%和0.723,其中,增强MRI组诊断方法的AUC明显高于MRCP组(P=0.0465)。结论增强MRI在鉴别诊断IPMN良恶性时较MRCP价值更大。 Objective To compare the value of liver acquisition with volume acceleration (LAVA) and magnetic resonance cholangiopancreatography (MRCP) in diagnosing benign and malignant intraductal pa- pillary mucinous neoplasms (IPMN) of the pancreas. Methods The MR findings of 35 IPMN patients confirmed by pathology were analyzed retrospectively, and the sequences included TIWI, T2WI, LAVA, and MRCP. All patients were divided into two groups: the group of MRI enhancement (including T1WI, T2WI, and MRI enhancement) and the group of MRCP (including T1WI, T2WI, and MRCP). Two groups were evaluated by the receiver operating characteristic (ROC) curve. Results Totally 23 cases of intraductal papillary mucinous tumors and 12 cases of intraductal papillary mucinous carcinomas were diagnosed. Finally, 29 cases (29/35) of IPMN were diagnosed correctly in the group of MR enhancement, and 25 cases (25/35) diagnosed correctly in the group of MRCP. The differential diagnostic accuracy of the group of MRI enhancement (82. 9% ) was higher than that of the group of MRCP (71.4%), although the difference was not statistically significant (P =0. 068). The sensitivity, specificity, positive predictive value, and the area under the ROC curve (AUC) of the group of MRI enhancement were 83.3%, 82. 6%, 71.4%, and 0. 850, and those of the group of MRCP were 75.0%, 69.6%, 52. 3%, and O. 723. The AUC of the group of MRI enhancement was significantly larger than that of the group of MRCP (P = 0. 0465 ). Conclusion MRI enhancement is more valuable than MRCP in the differential diagnosis of benign and malignant IPMN.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2014年第1期98-101,共4页 Acta Academiae Medicinae Sinicae
关键词 胰腺 肿瘤 囊性 磁共振胆胰管成像 诊断 pancreas tumor, cystic magnetic resonance cholangiopancreatography diagnosis
  • 相关文献

参考文献13

  • 1周康荣,严福华,曾蒙苏.腹部CT诊断学[M].上海:复旦大学出版社,2010:879-883.
  • 2Allen PJ,Angelica M,Gonen M,et al.A selective approach to the resection of cystic lesions of the pancreas:results from 539 consecutive patients[J].Ann Surg,2006,244(4):572-582.
  • 3Wang Y,Miller FH,Chen ZE,et al.Diffusion-weighted MR imaging of solid and cystic lesions of the pancreas[J].Radiographics,2011,31(3):47-64.
  • 4Kalb B,Sarmiento JM,Kooby DA,et al.MR imaging of cystic lesions of the pancreas[J].Radiographics,2009,29(6):1749-1765.
  • 5Song SJ,Lee JM,Kim YJ,et al.Differentiation of intraductal papillary mucinous neoplasms from orther pancreatic cycstic masses:comparison of multirow-detector CT and MR imaging using ROC analysis[J].Magn Reson Imaging,2007,26(1):86-93.
  • 6Silas AM,Morrin MM,Raptopoulos V,et al.Intraductal papillary mucinous tumors of the pancreas[J].AJR Am J Roentgenol,2001,176(1):179-185.
  • 7Irie H,Honda H,Aibe H,et al.MR cholangiopancreatographic differentiation of benign and malignant intraductal mucin-producing tumors of the pancreas[J].AJR Am J Roentgenol,2000,174(5):1403-1408.
  • 8范飞,胡先贵,张怡杰,杨珏,杨晓宇.良恶性胰腺导管内乳头状瘤的临床及影像特征[J].第二军医大学学报,2008,29(2):193-196. 被引量:14
  • 9Sun HY,Kim SH,Kim MA,et al.CT imaging spectrum of pancreatic serous tumors:Based on new pathologic classification[J].Eur Radiol,2010,75(2):45-55.
  • 10Kim SY,Lee JM,Kim SH,et al.Macrocystic neoplasms of the pancreas:CT differentiation of serous oligocystic adenoma from mucinous cyst-adenoma and intraductal papillary mucinous tumor[J].AJR Am J Roentgenol,2006,187(5):1192-1198.

二级参考文献13

  • 1Kimura W, Sasahira N, Yoshikawa T, Muto T, Makuuchi M. Duct-ectatic type of mucin-producing tumor of the pancreas: new concept of pancreatic neoplasia[J]. Hepatogastroenterology, 1996,43 : 692-709.
  • 2Sharma M S,Brams D M,Birkett D H,Munson J L. Uncinatectomy: a novel surgical option for the management of intraductal papillary mucinous tumors of the pancreas[J]. Dig Surg, 2006,23(1-2) : 121-124.
  • 3Itoh T, Hirooka Y, Itoh A, Hashimoto S, Kawashima H, Hara K, et al. Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas[J]. Am J Gastroenterol,2005,100:144- 152.
  • 4Chiu S S,Lim J H,Lee W J,Chang K T,Oh D K,Lee K T,et al. Intraductal papillary mucinous tumour of the pancreas: differentiation of malignancy and benignancy by CT[J]. Clin Radiol,2006,61 :776-783.
  • 5Pilleul F, Rochette A, Partensky C, Scoazec J Y, Bernard P, Valette P J. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings[J]. J Magn Reson Imaging,2005,21:237-244.
  • 6Pais S A, Attasaranya S, Leblanc J K, Sherman S, Schmidt C M,DeWitt J. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology[J]. Clin Gastroenterol Hepatol, 2007, 5:489-495.
  • 7Kitagawa Y, Unger T A, Taylor S, Kozarek R A, Traverso L W. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas[J]. J Gastrointest Surg,2003,?:12-19.
  • 8Choi B S,Kim T K,Kim A Y,Kim K W,Park S W,Kim P N,et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography[J]. Korean J Radiol, 2003, 4:157-162.
  • 9Kawai M, Uchiyama K, Tani M, Onishi H, Kinoshita H, Ueno M,et al. Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas: the differential diagnosis from benign entities[J]. Arch Surg, 2004, 139: 188- 192.
  • 10Sugiyama M, Atomi Y. Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies[J]. Ann Surg, 1998,228 : 685-691.

共引文献27

同被引文献56

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部